Sudesna Chatterjee

3.6k total citations · 1 hit paper
29 papers, 2.6k citations indexed

About

Sudesna Chatterjee is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, Sudesna Chatterjee has authored 29 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 7 papers in Physiology. Recurrent topics in Sudesna Chatterjee's work include Diabetes Management and Research (15 papers), Diabetes Treatment and Management (15 papers) and Pancreatic function and diabetes (7 papers). Sudesna Chatterjee is often cited by papers focused on Diabetes Management and Research (15 papers), Diabetes Treatment and Management (15 papers) and Pancreatic function and diabetes (7 papers). Sudesna Chatterjee collaborates with scholars based in United Kingdom, Australia and Belarus. Sudesna Chatterjee's co-authors include Melanie J. Davies, Kamlesh Khunti, Jane Speight, Frank J. Snoek, Simon Heller, Hertzel C. Gerstein, Sophia Zoungas, Ido Weinberg, Danielle H. Bodicoat and Samuel Seidu and has published in prestigious journals such as The Lancet, Diabetologia and Drugs.

In The Last Decade

Sudesna Chatterjee

29 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type 2 diabetes

2017 1.8k citations Sudesna Chatterjee, Kamlesh Khunti et al. The Lancet profile →

Peers

Countries citing papers authored by Sudesna Chatterjee

Since Specialization

Citations

This map shows the geographic impact of Sudesna Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sudesna Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sudesna Chatterjee more than expected).

Fields of papers citing papers by Sudesna Chatterjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sudesna Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sudesna Chatterjee. The network helps show where Sudesna Chatterjee may publish in the future.

Co-authorship network of co-authors of Sudesna Chatterjee

This figure shows the co-authorship network connecting the top 25 collaborators of Sudesna Chatterjee. A scholar is included among the top collaborators of Sudesna Chatterjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sudesna Chatterjee. Sudesna Chatterjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effects of empagliflozin, dietary energy restriction, or both on appetite‐regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double‐blind, placebo‐controlled trial 2022 ·Diabetes Obesity and Metabolism ·Jack A. Sargeant, James A. King, Thomas Yates, (unknown), Danielle H. Bodicoat, Sudesna Chatterjee, Charlotte L. Edwardson, Laura J. Gray, Benoit Poulin, Ghazala Waheed, Helen L. Waller, David R. Webb, Scott A. Willis, John Wilding, Kamlesh Khunti, David J. Stensel, Melanie J. Davies	10
2	Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes 2019 ·Drugs ·Sudesna Chatterjee, Kamlesh Khunti, Melanie J. Davies	11
3	Rationale and design of a cross-sectional study to investigate and describe the chronotype of patients with type 2 diabetes and the effect on glycaemic control: the CODEC study 2019 ·BMJ Open ·Emer M. Brady, Andrew P. Hall, (unknown), Sudesna Chatterjee, (unknown), Charlotte L. Edwardson, Kamlesh Khunti, (unknown), Joseph Henson, Alex V. Rowlands, Alice C. Smith, Thomas Yates, Melanie J. Davies	21
4	Physical Activity after Cardiac EventS (PACES) – a group education programme with subsequent text-message support designed to increase physical activity in individuals with diagnosed coronary heart disease: study protocol for a randomised controlled trial 2018 ·Trials ·Louisa Herring, Helen Dallosso, Sudesna Chatterjee, Danielle H. Bodicoat, (unknown), Kamlesh Khunti, Tom Yates, Samuel Seidu, Ian Hudson, Melanie J. Davies	14
5	Accurate diagnosis of diabetes mellitus and new paradigms of classification 2018 ·Nature Reviews Endocrinology ·Sudesna Chatterjee, Melanie J. Davies	10
6	Do sulphonylureas still have a place in clinical practice? 2018 ·The Lancet Diabetes & Endocrinology ·Kamlesh Khunti, Sudesna Chatterjee, Hertzel C. Gerstein, Sophia Zoungas, Melanie J. Davies	89
7	What have we learnt from “real world” data, observational studies and meta‐analyses 2018 ·Diabetes Obesity and Metabolism ·Sudesna Chatterjee, Melanie J. Davies, Kamlesh Khunti	31
8	Predicting hospital stay, mortality and readmission in people admitted for hypoglycaemia: prognostic models derivation and validation 2017 ·Diabetologia ·Francesco Zaccardi, David R. Webb, Melanie J. Davies, Nafeesa Dhalwani, Laura J. Gray, Sudesna Chatterjee, Gemma Housley, Dominick Shaw, (unknown), Kamlesh Khunti	2
9	Type 2 diabetes breakdown → 2017 ·The Lancet ·Sudesna Chatterjee, Kamlesh Khunti, Melanie J. Davies	1847
10	Diabetes structured self-management education programmes: a narrative review and current innovations 2017 ·The Lancet Diabetes & Endocrinology ·Sudesna Chatterjee, Melanie J. Davies, Simon Heller, Jane Speight, Frank J. Snoek, Kamlesh Khunti	245
11	Pharmaceutical Interventions for Diabetes Prevention in Patients at Risk 2017 ·American Journal of Cardiovascular Drugs ·Sudesna Chatterjee, Melanie J. Davies, Kamlesh Khunti	3
12	New drug treatments versus structured education programmes for type 2 diabetes: comparing cost-effectiveness 2016 ·The Lancet Diabetes & Endocrinology ·Kamlesh Khunti, Sudesna Chatterjee, Marian Carey, Heather Daly, (unknown), Melanie J. Davies	8
13	Optimizing management of glycaemia 2016 ·Best Practice & Research Clinical Endocrinology & Metabolism ·Sudesna Chatterjee, Kamlesh Khunti, Melanie J. Davies	8
14	The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies 2016 ·Clinical Pharmacology Advances and Applications ·Melanie J. Davies, Sudesna Chatterjee, Kamlesh Khunti	55
15	Use of SGLT2 inhibitors during Ramadan: a survey of physicians’ views and practical guidance 2016 ·British Journal of Diabetes ·Salem Beshyah, Sudesna Chatterjee, Melanie J. Davies	14
16	Development of a lifestyle intervention using the MRC framework for diabetes prevention in people with impaired glucose regulation 2015 ·Journal of Public Health ·Jacqui Troughton, Sudesna Chatterjee, (unknown), Heather Daly, (unknown), Margaret Stone, Naina Patel, Kamlesh Khunti, Thomas Yates, Laura J. Gray, Melanie J. Davies	21
17	Type 2 diabetes: recent advances in diagnosis and management 2015 ·Prescriber ·Sudesna Chatterjee, Melanie J. Davies	3
18	Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage: A Meta-Analysis 2014 ·Journal of Vascular Surgery ·Sudesna Chatterjee, (unknown), Ido Weinberg	34
19	Ethnic differences in body composition in adolescents 2007 ·Primary care diabetes ·Margaret Stone, Lisa Williams, Sudesna Chatterjee, Melanie J. Davies, Kamlesh Khunti	11
20	Insulin glargine and its place in the treatment of Types 1 and 2 diabetes mellitus 2006 ·Expert Opinion on Pharmacotherapy ·Sudesna Chatterjee, (unknown), Melanie J. Davies	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact